Under agenda item 6, it is proposed to grant discharge to the Board of Directors of Aercap. Given the lack of transparency of the remuneration report, which is not a separate voting item, we reflect our concerns over the remuneration at Aercap under this agenda item.
Under agenda item 10b and 10d, the board requests authorisation to restrict or exclude the pre-emptive rights allowed to shareholders when issuing new shares. The requested authorisation is 10%+10% of the share capital, and this exceeds our guidelines, which stipulate a maximum of 10% of the share capital. Therefore we recommend to OPPOSE.
Under agenda items 11a, 11b and 12 it is proposed to authorise the Board of Directors to repurchase and cancel shares. Given the absence of a dividend payment, we recommend shareholders OPPOSE these agenda items.